IDiyas

For the Inventor, By the Inventor

Palatine, IL, United States of America

Mark J Gattuso

USPTO Granted Patents = 12

Average Co-Inventor Count = 1.8

ph-index = 7

Forward Citations = 119(Granted Patents)


Location History:

  • Palantine, IL (US) (1993)
  • Palatine, IL (US) (1987 - 2002)

Company Filing History:

goldMedal12 out of 5,540 
 
Uop Lcc
 patents

Years Active: 1987-2002

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6458955 - Process for preparation of pharmaceutically desired enantiomers (2002-10-01),
2. 6455736 - Process for preparation of pharmaceutically desired sertraline and sertraline analogs (2002-09-24),
3. 6410794 - Process for preparation of pharmaceutically desired chiral tetralone from tetralones (2002-06-25),
4. 6162949 - Process for preparation of the pharmaceutically desired (S)-oxetine (2000-12-19),
5. 5889186 - Process for preparation of the pharmaceutically desired (S)-oxetine (1999-03-30),
6. 5470890 - Bis-(N-alkylaminocyclohexyl)methanes as curing agents in polyurethane (1995-11-28),
7. 5312886 - Bis(N-alkylaminocyclohexyl)methanes as curing agents for polyurethanes (1994-05-17),
8. 5288768 - Urea-modified isocyanurates (1994-02-22),
9. 5223551 - Urea-modified isocyanurates and method of making rigid foams thereof (1993-06-29),
10. 5166185 - Chlorofluorocarbon-free flexible polyurethane foams and method of making (1992-11-24),
11. 4734540 - Catalyst for the selective hydrogenation of polyunsaturated organics (1988-03-29),
12. 4695560 - Catalyst for the selective hydrogenation of diolefinic hydrocarbons (1987-09-22),

Title: Mark J Gattuso: Innovator in Pharmaceutical Processes

Introduction

Mark J Gattuso is a notable inventor based in Palatine, IL (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 12 patents, showcasing his innovative approach to drug synthesis and purity.

Latest Patents

Gattuso's latest patents include a "Process for preparation of pharmaceutically desired enantiomers." This patent focuses on improved processes for achieving high enantiomeric purity through resolution using simulated moving bed chromatography. The method allows for the racemization and recycling of undesired enantiomers, ensuring minimal loss during the synthesis process. Another significant patent is the "Process for preparation of pharmaceutically desired sertraline and sertraline analogs." This invention also emphasizes high enantiomeric purity and incorporates similar techniques for recycling undesired isomers.

Career Highlights

Gattuso is currently associated with UOP LLC, where he applies his expertise in pharmaceutical processes. His work has significantly impacted the efficiency and effectiveness of drug development, particularly in achieving high purity levels in pharmaceutical compounds.

Collaborations

Throughout his career, Gattuso has collaborated with esteemed colleagues, including David W House and Ray V Scott, Jr. These partnerships have fostered innovation and advancement in their respective fields.

Conclusion

Mark J Gattuso's contributions to pharmaceutical processes through his patents reflect his dedication to innovation and excellence in drug synthesis. His work continues to influence the industry, paving the way for advancements in pharmaceutical purity and efficiency.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…